Drug & medication recalls Moderate risk

SOLIRIS 1200 MG QS NACL0 recalled over sterility concerns

Recall date
June 12, 2019
Source
U.S. Food & Drug Administration (FDA) — enforcement report
Official notice title
Infusion Options, Inc. recalls SOLIRIS 1200 MG QS 240 ML NACL0.9% IVPB; SOLIRIS 900 MG QS 180 ML NACL 0.9% IVPB, Rx Only, Infusion Options, Inc. 5924…
Recall number
D-1813-2019
FDA classification
Class II
Brand / firm
Infusion Options, Inc.
Sold / distributed
NY only

Why it was recalled

Lack of Assurance of Sterility

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

SOLIRIS 1200 MG QS 240 ML NACL0.9% IVPB; SOLIRIS 900 MG QS 180 ML NACL 0.9% IVPB, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233

Get recall alerts

Free email alert whenever Infusion Options, Inc. has a new recall — straight from official government data. Unsubscribe anytime.

More recalls from: Infusion Options, Inc.